Zurueck zur Suche

Reporte zur Charge N234J

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 AK 1 ID 1

VAERS 1337942

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge N234J

moderat
Staat
TX
Alter
11,0
Geschlecht
F
Eingang
21.05.2021
Impfdatum
17.05.2021
Beginn
17.05.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Fear Headache Palpitations Tearfulness

Symptomtext

1315-approx. 10 minutes after administration patient c/o headache, states she feels like her heart racing with palpitations. Pt is awake and alert, oriented, conversational and able to follow commands. Resp even and unlabored, rate 16. Skin warm and dry with slight pallor. Pt assisted from chair where she was seated to gurney and encouraged to lay down, and breath deeply; pt complied. Blood pressure obtained and recorded; results wnl for age and situation. Pt became tearful, stated she was crying due to h/a 5/10 and states she is scared. Patient reassured and cool moist compress applied to forehead. Continued monitoring in observation area for additional 15 minutes, during this time Patient able to sit up, at a banana, drink water, talk with parent and siblings, no longer tearful. At reassessment pt awake and alert, oriented, respiratations even/unlabored, 18/min; Skin warm and dry, normal color, no pallor noted; states she feels better, denies pain. Parent states she has episodes of anxiety, during which she has similar complaints. VS again obtained and WNL. Pt able to stand and walk, denies lightheaded, no s/s of syncope; no s/s discomfort or distress. No further complaints from pt at this time. Family instructed on post-vaccine comfort measures before departing. Medical Director notified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
DENIES
Vorgeschichte
Denies
Andere Medikamente
Denies
Allergien
EGG, PORK-DERIVED
Vorherige Impfungen
-

VAERS 2084718

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge N234J

gering
Staat
-
Alter
-
Geschlecht
M
Eingang
03.02.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received a dose that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received HBV (Engerix B) (batch number N234J, expiry date 21st January 2022) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 26th January 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 26th January 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was unknown. Medical assistant reported that a patient received an expired dose of Engerix B, which led to expired vaccine used. The Vaccine Administration Facility was the same as Primary Reporter. The reporter did not consent to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2041962

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge N234J

gering
Staat
AK
Alter
47,0
Geschlecht
F
Eingang
18.01.2022
Impfdatum
11.01.2022
Beginn
11.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose Product administered to patient of inappropriate age

Symptomtext

The patient inadvertently received pediatric dose (10mcg); The patient inadvertently received pediatric dose (10mcg); This case was reported by a nurse via call center representative and described the occurrence of accidental underdose in a 47-year-old female patient who received HBV (Engerix B pediatric) (batch number N234J, expiry date 21st January 2022) for prophylaxis. On 11th January 2022, the patient received the 3rd dose of Engerix B pediatric (intramuscular) 10 ug. On 11th January 2022, unknown after receiving Engerix B pediatric, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown. Additional details were provided as follows: The reporter reported that, the patient inadvertently received pediatric dose (10mcg) of Engerix-B in the right arm, which led to accidental underdose and adult use of a child product. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1577434

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge N234J

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
17.08.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

exposed to freezing conditions; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HBV (Engerix B) (batch number N234J, expiry date 21st January 2022), (batch number LM992, expiry date 13th December 2022), (batch number 5295P, expiry date 27th December 2022), (batch number 73H93, expiry date 10th January 2022) and (batch number 2H575, expiry date 12th September 2022) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number 3332B, expiry date 5th March 2023) and (batch number 9X3T5, expiry date 5th March 2023) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-IPV (Kinrix) (batch number 3DZ45, expiry date 15th January 2022), (batch number PX27D, expiry date 17th January 2023), (batch number 7P5J5, expiry date 30th September 2022) and (batch number HB7L7, expiry date 31st August 2002) for prophylaxis, dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) (batch number 374LB, expiry date 28th June 2022), (batch number X99KA, expiry date 28th October 2022) and (batch number GC5NG, expiry date 1st April 2023) for prophylaxis, Rota (Rotarix lyophilized formulation) (batch number E4447, expiry date 6th July 2022) for prophylaxis, rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis, HAV (Havrix) (batch number 7HJ74, expiry date 21st August 2022), (batch number G99R4, expiry date 20th May 2022) and (batch number 7J3G3, expiry date 12th June 2022) for prophylaxis, DTPa (Infanrix) (batch number XG942, expiry date 22nd August 2022) and (batch number 4L9E4, expiry date 7th February 2023) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) (batch number 3PP42, expiry date 16th March 2022) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Engerix B. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Pediarix. On an unknown date, the dose was an unknown dose. On an unknown date, the patient started Pediarix Pre-Filled Syringe Device and Kinrix. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient started Kinrix Pre-Filled Syringe Device and Boostrix. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Rotarix lyophilized formulation, Rotarix Oral Applicator Device and Havrix. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Infanrix. On an unknown date, the dose was an unknown dose. On an unknown date, the patient started Infanrix Pre-Filled Syringe Device, Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B, Pediarix, Pediarix Pre-Filled Syringe Device, Kinrix, Kinrix Pre-Filled Syringe Device, Boostrix, Rotarix lyophilized formulation, Rotarix Oral Applicator Device, Havrix, Infanrix, Infanrix Pre-Filled Syringe Device, Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional case details were provided as follows: The age at vaccination was not reported. Health care professional reported several temperature excursions during the last month on which various vaccines were exposed to freezing conditions for different amounts of time which led to incorrect storage of drug. The reporter provided vaccines involved and lot numbers. Could not confirm if follow-up could be possible since health care professional stated he/she not the supervisor, but I caould ask them later. Health care professional was willing to be contacted at a later time, via email, to confirm follow-up. No patient information was collected since health care professional would have to review all records for last month to determine which patients received what vaccines and if those vaccines had a prior temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1549314

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge N234J

gering
Staat
ID
Alter
5,0
Geschlecht
M
Eingang
12.08.2021
Impfdatum
06.08.2021
Beginn
06.08.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Client was mistakenly given BOTH Kinrix IM vaccine and IPV vaccine SQ. Error was realized while charting. I phoned my supervisor, RN and reported the error to her. Incident report was filed. Mother was phoned several times that day and a message was left for her to contact us. VAERS report filed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
NKA
Vorherige Impfungen
-